다발성 골수종 환자의 삶의 질

목차 (Table of Contents)

• 서론
• 연구방법
• 연구결과
• 논의
• 결론 및 제언
• REFERENCES

참고문헌 (Reference)

1 정지연, "항암화학요법을 받은 입원 암환자의 삶의 질에 영향을 미치는 요인" 대한종양간호학회 12 (12): 84-91, 2012

2 김경덕, "항암화학요법을 받는 췌장암 환자의 통증, 수면장애, 피로가 삶의 질에 미치는 영향" 대한종양간호학회 12 (12): 117-124, 2012

3 조옥희, "항암화학요법으로 인한 탈모 암 환자의 기분상태, 대인관계 불안 및삶의 질" 대한종양간호학회 13 (13): 193-200, 2013

4 김정혜, "항암화학요법으로 인한 말초신경병증을 경험하는 대장암 환자의 삶의 질" 대한종양간호학회 11 (11): 254-262, 2011

5 송병은, "조혈모세포 이식환자의 삶의 질" 대한종양간호학회 8 (8): 40-49, 2008

6 김혜영, "유방암 환자의 항암화학요법으로 인한 말초신경병증과 삶의 질" 대한종양간호학회 13 (13): 222-230, 2013

7 정경희, "대장암 환자 증상군의 중증도에 따른 삶의 질" 대한종양간호학회 14 (14): 74-83, 2014

8 김혜숙, "다발성 골수종 환자의 삶의 질 영향요인" 대한종양간호학회 15 (15): 9-17, 2015

9 양지연, "갑상선암 수술 환자들의 삶의 질에 영향을 미치는 요인" 대한종양간호학회 15 (15): 59-66, 2015

10 Thomas R. Osborne, "What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools" Wiley-Blackwell 89 (89): 437-457, 2012

11 Shaji Kumar, "Treatment of newly diagnosed multiple myeloma: advances in current therapy" Springer Nature 27 (27): S14-S24, 2010

12 Oken MM, "Toxicity and response criteria of the eastern cooperative oncology group" 5 (5): 649-655, 1982

13 Sandra Kurtin, "The Changing Landscape of Multiple Myeloma" Oncology Nursing Society (ONS) 17 (17): 7-11, 2013

14 Elizabeth Bilotti, "Survivorship Care Guidelines for Patients Living With Multiple Myeloma" Oncology Nursing Society (ONS) 15 (15): 5-8, 2011

15 A. Palumbo, "Shifts in the Therapeutic Paradigm for Patients Newly Diagnosed with Multiple Myeloma: Maintenance Therapy and Overall Survival" American Association for Cancer Research (AACR) 17 (17): 1253-1263, 2011

16 P Sonneveld, "Review of health-related quality of life data in multiple myeloma patients treated with novel agents" Springer Nature 27 (27): 1959-1969, 2013

17 Miller AB, "Reporting results of cancer treatment" 47 (47): 207-214, 1981

18 Kontodimopoulos N, "Reliability and validity of the Greek QLQ-C30 and QLQMY20for measuring quality of life in patients with multiple myeloma" 2012 : 842-867, 2012

19 Melda Cömert, "Quality of Life and Supportive Care in Multiple Myeloma" Journal of Clinical Research of Pediatric Endocrinology 30 (30): 234-246, 2013

20 Alhossain A. Khalafallah, "QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION" Institute of Hematology, Catholic University 3 (3): e2011057-, 2011

21 Anne C. Kirchhoff, "Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation" Springer Nature 4 (4): 33-44, 2010

22 Julia A. Goodwin, "Personal Financial Effects of Multiple Myeloma and Its Treatment" Ovid Technologies (Wolters Kluwer Health) 36 (36): 301-308, 2013

23 D. Smith, "Multiple myeloma" BMJ 346 (346): f3863-, 2013

24 Alessandro Corso, "Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis" Public Library of Science (PLoS) 8 (8): e75047-, 2013

25 Karin Jordan, "Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study" Springer Nature 22 (22): 417-426, 2014

26 Stead ML, "Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life" 104 (104): 605-611, 1999

27 Beth Faiman, "Clinical Updates and Nursing Considerations for Patients With Multiple Myeloma" Oncology Nursing Society (ONS) 11 (11): 831-840, 2007

28 Allen C. Sherman, "Changes in Quality-of-Life and Psychosocial Adjustment among Multiple Myeloma Patients Treated with High-Dose Melphalan and Autologous Stem Cell Transplantation" Elsevier BV 15 (15): 12-20, 2009

29 K. Cocks, "An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma" Elsevier BV 43 (43): 1670-1678, 2007

30 Gulbeyaz Can, "A comparison of men and women's experiences of chemotherapy-induced alopecia" Elsevier BV 17 (17): 255-260, 2013